Clinical Trials List
Protocol NumberTYR430-101
Not yet recruiting
2025-03-31 - 2028-05-06
Phase I
Recruiting2
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- 吳紋綺 Division of Hematology & Oncology
- 唐振育 Division of Hematology & Oncology
- Tien-Hua Chen Division of Hematology & Oncology
- Muh-Hwa Yang Division of Hematology & Oncology
- Hao-Wei Teng Division of Hematology & Oncology
- Hung-Yuan Yu Digestive System Department
- 李癸汌 Digestive System Department
- Yi-Ping Hung Division of Hematology & Oncology
- San-Chi Chen Division of Hematology & Oncology
- Yi-Hsiang Huang Digestive System Department
- Chun-Yu Liu Division of Hematology & Oncology
- Chueh-Chuan Yen Division of Hematology & Oncology
- 呂學聖 Digestive System Department
- 姜乃榕 Division of Hematology & Oncology
- Shao-Jung Hsu Digestive System Department
- 陳宥任 Digestive System Department
- 齊振達 Digestive System Department
- Yun-Cheng Hsieh Digestive System Department
- 吳啟榮 Digestive System Department
- I-Cheng Lee Digestive System Department
- Mu-Hsin Chang Division of Hematology & Oncology
- Ming-Huang Chen Division of Hematology & Oncology
- Ta-Chung Chao Division of Hematology & Oncology
- Jiun-I Lai Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 吳宗哲 Division of Hematology & Oncology
- Chiun Hsu Division of Hematology & Oncology
- Ying-Chun Shen Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- Chih-Hung Hsu Division of Hematology & Oncology
- 呂理駿 Division of Hematology & Oncology
- YU-YUN SHAO Division of Hematology & Oncology
- TSUNG-HAO LIU Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
100 participants